Besides the traditional marker of OXPHOS dysfunction, the pathological increase of lactic acid [15], promising biomarkers for mitochondrial disease have been recently proposed, including fibroblast growth factor 21 (FGF21) [16, 17], GDF-15 [18], and creatine [19]. This evidence concerns the gene FGF21 and mitochondrial disease.